World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 130 2470 2302 119 115 1512 72096

Torsten Haferlach publications per year

The chart shows the history of publications by Torsten Haferlach between 1983 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Torsten Haferlach published across 43 years, from 1983 to 2025, averaging 38.5 papers a year. Output peaked at 108 publications in 2023. 137 of the 1,655 publications appeared in the last two years.

No. of publications
25 50 75 100
Bar chart. Horizontal axis: year, 1983 to 2025. Vertical axis: number of publications, 0 to 108. Peak 108 publications in 2023. 1983: 1 publication 1984: 1 publication 1985: 1 publication 1986: 2 publications 1987: 0 publications 1988: 0 publications 1989: 0 publications 1990: 0 publications 1991: 3 publications 1992: 0 publications 1993: 8 publications 1994: 4 publications 1995: 3 publications 1996: 7 publications 1997: 10 publications 1998: 8 publications 1999: 3 publications 2000: 6 publications 2001: 23 publications 2002: 17 publications 2003: 29 publications 2004: 56 publications 2005: 50 publications 2006: 50 publications 2007: 52 publications 2008: 44 publications 2009: 67 publications 2010: 66 publications 2011: 76 publications 2012: 90 publications 2013: 94 publications 2014: 68 publications 2015: 77 publications 2016: 76 publications 2017: 55 publications 2018: 59 publications 2019: 75 publications 2020: 63 publications 2021: 80 publications 2022: 86 publications 2023: 108 publications 2024: 56 publications 2025: 81 publications
1983 2025

1,655 publications in total across all disciplines

View publications per year as a table
Torsten Haferlach: publications per year, 1983 to 2025
Year Publications
1983 1
1984 1
1985 1
1986 2
1987 0
1988 0
1989 0
1990 0
1991 3
1992 0
1993 8
1994 4
1995 3
1996 7
1997 10
1998 8
1999 3
2000 6
2001 23
2002 17
2003 29
2004 56
2005 50
2006 50
2007 52
2008 44
2009 67
2010 66
2011 76
2012 90
2013 94
2014 68
2015 77
2016 76
2017 55
2018 59
2019 75
2020 63
2021 80
2022 86
2023 108
2024 56
2025 81
Total 1,655
Download as CSV

Torsten Haferlach publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Torsten Haferlach sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 1,501–1,520 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 1,512 publications — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14 1,512
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Torsten Haferlach D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Torsten Haferlach sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 130–131 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 130 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179 130
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Torsten Haferlach is affiliated with the MLL Munich Leukemia Laboratory in Germany. Their research primarily focuses on hematology, genetics, and molecular biology, with a significant emphasis on cancer research and immunology. The scientist's work contributes extensively to the understanding and treatment of various blood-related malignancies and disorders.

Haferlach's main fields of study include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these areas, they have specialized subfields such as:

  • Hematology
  • Genetics
  • Molecular Biology
  • Cancer Research
  • Immunology

The primary research topics addressed by Haferlach concern:

  • Acute Myeloid Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Chronic Myeloid Leukemia Treatments
  • Chronic Lymphocytic Leukemia Research
  • Acute Lymphoblastic Leukemia Research
  • Digital Imaging for Blood Diseases

Their publications have been featured predominantly in the following venues:

  • Blood
  • Leukemia
  • bioRxiv (Cold Spring Harbor Laboratory)
  • HemaSphere
  • Blood Advances

Torsten Haferlach has collaborated frequently with a number of co-authors including:

  • Manja Meggendorfer
  • Claudia Haferlach
  • Wolfgang Kern
  • Wencke Walter
  • Stephan Hütter

Notable recent publications by Haferlach include:

  • The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms, 2022, Leukemia
  • 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party, 2021, Blood
  • Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3-Internal Tandem Duplication Mutation (SORMAIN), 2020, Journal of Clinical Oncology
  • SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS, 2020, Blood
  • Mechanisms of antigen escape from BCMA- or GPRC5D-targeted immunotherapies in multiple myeloma, 2023, Nature Medicine

Best Publications

  • Landscape of genetic lesions in 944 patients with myelodysplastic syndromes

    T Haferlach;Y Nagata;V Grossmann;Y Okuno

  • Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease.

    Susanne Schnittger;Claudia Schoch;Martin Dugas;Wolfgang Kern

  • BRAF mutations in hairy-cell leukemia

    Enrico Tiacci;Vladimir Trifonov;Gianluca Schiavoni;Antony Holmes

  • Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party.

    Gerrit J. Schuurhuis;Michael Heuser;Sylvie Freeman;Marie Christine Béne

  • Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype

    Susanne Schnittger;Claudia Schoch;Wolfgang Kern;Cristina Mecucci

  • Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Subclassification of Leukemia: Report From the International Microarray Innovations in Leukemia Study Group

    Torsten Haferlach;Alexander Kohlmann;Lothar Wieczorek;Giuseppe Basso

  • Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes.

    Peter Valent;Amy D. Klion;Hans-Peter Horny;Florence Roufosse

  • Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications.

    Guido Marcucci;Torsten Haferlach;Hartmut Döhner

  • Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference

    Peter Valent;Hans-Peter Horny;John M. Bennett;Christa Fonatsch

  • Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia

    Rongqing Pan;Leah J. Hogdal;Juliana M. Benito;Donna Bucci

  • Landscape Of Genetic Lesions In 944 Patients With Myelodysplastic Syndromes

    Yasunobu Nagata;Vera Grossmann;Yusuke Okuno;Ulrike Bacher

  • Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin

    Ramiro Garzon;Michela Garofalo;Maria Paola Martelli;Roger Briesewitz

  • Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor)

    Norbert Schmitz;Peter Dreger;Meinolf Suttorp;Ernst B. Rohwedder

  • AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.

    Thomas Pabst;Beatrice U. Mueller;Nari Harakawa;Claudia Schoch

  • Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia

    Raphaël Itzykson;Olivier Kosmider;Aline Renneville;Véronique Gelsi-Boyer

  • KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival

    Susanne Schnittger;Tobias M. Kohl;Torsten Haferlach;Wolfgang Kern

  • Prognostic relevance of FLT3-TKD mutations in AML: the combination matters—an analysis of 3082 patients

    Ulrike Bacher;Claudia Haferlach;Wolfgang Kern;Torsten Haferlach

  • Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative Group.

    Thomas Büchner;Wolfgang Hiddemann;Bernhard Wörmann;Helmut Löffler

  • IDH1 mutations are detected in 6.6% of 1414 AML patients and are associated with intermediate risk karyotype and unfavorable prognosis in adults younger than 60 years and unmutated NPM1 status

    Susanne Schnittger;Claudia Haferlach;Madlen Ulke;Tamara Alpermann

  • Frequent Pathway Mutations of Splicing Machinery in Myelodysplasia

    Kenichi Yoshida;Masashi Sanada;Yuichi Shiraishi;Daniel Nowak

Frequent Co-Authors

Wolfgang Kern
Wolfgang Kern Munich Leukemia Laboratory (Germany)
Claudia Haferlach
Claudia Haferlach Ludwig-Maximilians-Universität München
Susanne Schnittger
Susanne Schnittger Ludwig-Maximilians-Universität München
Claudia Schoch
Claudia Schoch MLL Munich Leukemia Laboratory
Wolfgang Hiddemann
Wolfgang Hiddemann Ludwig-Maximilians-Universität München
Martin Dugas
Martin Dugas Heidelberg University
Seishi Ogawa
Seishi Ogawa Kyoto University
Jaroslaw P. Maciejewski
Jaroslaw P. Maciejewski Cleveland Clinic
Nicholas C.P. Cross
Nicholas C.P. Cross University of Southampton
Mikkael A. Sekeres
Mikkael A. Sekeres Cleveland Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine doesn’t always mean becoming a doctor. The healthcare field offers a variety of rewarding paths that can be started or advanced through online education. Many students are looking for flexible, affordable ways to grow their careers, making online programs increasingly popular in the U.S.

For those interested in leadership and management roles, an online master of health administration can open doors to jobs across hospitals, clinics, and health organizations. To keep tuition costs down, students often search for the cheapest mha online programs that don’t compromise on quality or accreditation.

Nursing professionals can advance further by choosing one of the cheapest online bsn to dnp programs, earning the highest clinical nursing degree online. Additionally, those fascinated by pharmaceuticals may pursue online pharmacy programs for advanced pharmacy practice and leadership.

Exploring these online options provides flexibility, financial savings, and a valuable way to start or advance a healthcare career—no matter where you live.

Best Scientists Citing Torsten Haferlach

Trending Scientists

Recently Published Articles